Susquehanna International Group, LLP Emergent Bio Solutions Inc. Transaction History

Susquehanna International Group, LLP

$823 Billion
Q3 2025

A detailed history of Susquehanna International Group, LLP transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 278,953 shares of EBS stock, worth $2.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

278,953

Previous 243,797 14.42%

Holding current value

$2.82 Million

Previous $1.56 Million 58.2%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$5.63 - $9.32 $197,928 - $327,653	35,156 Added 14.42%	278,953 $2.46 Million
Q2 2025 Aug 14, 2025	SELL	$4.26 - $6.94 $2.58 Million - $4.2 Million	-605,576 Reduced 71.3%	243,797 $1.56 Million
Q1 2025 May 14, 2025	SELL	$4.66 - $11.66 $332,770 - $832,640	-71,410 Reduced 7.76%	849,373 $4.13 Million
Q4 2024 Feb 14, 2025	BUY	$7.72 - $11.97 $3.68 Million - $5.7 Million	476,118 Added 107.07%	920,783 $8.8 Million
Q3 2024 Nov 14, 2024	BUY	$5.72 - $14.77 $1.26 Million - $3.25 Million	220,162 Added 98.07%	444,665 $3.71 Million

Q2 2024 Aug 15, 2024	BUY	$1.86 - $6.98 $417,575 - $1.57 Million	224,503 New	224,503 $1.53 Million
Q4 2023 Feb 14, 2024	SELL	$1.82 - $3.16 $544,190 - $944,858	-299,006 Reduced 84.45%	55,059 $132,000
Q3 2023 Nov 14, 2023	BUY	$3.17 - $7.91 $209,384 - $522,471	66,052 Added 22.93%	354,065 $1.2 Million
Q2 2023 Aug 11, 2023	SELL	$7.35 - $13.21 $1.96 Million - $3.53 Million	-266,925 Reduced 48.1%	288,013 $2.12 Million
Q1 2023 May 16, 2023	BUY	$7.79 - $16.29 $3.97 Million - $8.3 Million	509,520 Added 1121.85%	554,938 $5.75 Million
Q4 2022 Feb 14, 2023	SELL	$11.0 - $21.45 $570,361 - $1.11 Million	-51,851 Reduced 53.31%	45,418 $536,000
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $1.38 Million - $2.47 Million	68,858 Added 242.36%	97,269 $2.04 Million
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $443,381 - $705,497	-16,170 Reduced 36.27%	28,411 $882,000
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $1.87 Million - $2.68 Million	-51,337 Reduced 53.52%	44,581 $1.83 Million
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $1.32 Million - $2.19 Million	39,836 Added 71.03%	95,918 $4.17 Million
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $145,703 - $192,205	2,910 Added 5.47%	56,082 $2.81 Million
Q2 2021 Aug 11, 2021	BUY	$56.61 - $80.46 $230,006 - $326,908	4,063 Added 8.27%	53,172 $3.35 Million
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $2.42 Million - $3.51 Million	-28,018 Reduced 36.33%	49,109 $4.56 Million
Q4 2020 Feb 16, 2021	SELL	$79.17 - $111.47 $4.4 Million - $6.2 Million	-55,583 Reduced 41.88%	77,127 $6.91 Million
Q3 2020 Nov 16, 2020	BUY	$81.91 - $134.94 $9.09 Million - $15 Million	110,926 Added 509.21%	132,710 $13.7 Million
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $1.13 Million - $1.87 Million	-20,863 Reduced 48.92%	21,784 $1.72 Million
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $814,060 - $1.13 Million	16,499 Added 63.1%	42,647 $2.47 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $1.54 Million - $1.78 Million	-30,110 Reduced 53.52%	26,148 $1.41 Million
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $75,394 - $106,220	-1,857 Reduced 3.2%	56,258 $2.94 Million
Q2 2019 Aug 16, 2019	BUY	$39.92 - $53.86 $513,850 - $693,285	12,872 Added 28.45%	58,115 $2.81 Million
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $1.41 Million - $1.9 Million	35,329 Added 356.35%	45,243 $2.19 Million
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $374,451 - $473,393	9,914	9,914 $461,000

Others Institutions Holding EBS

# of Institutions

192

Shares Held

41.5M

Call Options Held

899K

Put Options Held

256K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $504M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Emergent Bio Solutions Inc. Transaction History